Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 1/20 | 0.48 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.42 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.40 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.39 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.39 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.39 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.38 |
| ▸ | AR | P10275 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13290007 | 0.98 | ESR2 (0.50) | ESR2HSD17B1HSD17B2TAAR1CYP1A1 | |
| SCHEMBL13290004 | 0.90 | ESR2 (0.53) | ESR2HSD17B1HSD17B2TAAR1CYP1A1 | |
| SCHEMBL13290032 | 0.77 | MAPT (0.55) | MAPTNOTUMCES2 | |
| SCHEMBL13290009 | 0.76 | SERPINE1 (0.41) | ESR2MAPTCES2CES1 | |
| SCHEMBL12432447 | 0.76 | MAPT (0.56) | CYP1B1MEN1MAPTKMT2AAR | |
| SCHEMBL13290029 | 0.75 | MAPT (0.56) | MAPTNOTUMCES2 | |
| SCHEMBL2202541 | 0.74 | SERPINE1 (0.42) | ESR2MAPTCES2CES1 | |
| SCHEMBL2203880 | 0.73 | MAPT (0.59) | CYP1B1MEN1MAPTKMT2AAR | |
| SCHEMBL14278528 | 0.73 | TAAR1 (0.39) | ESR2TAAR1CYP1A2NOTUMPTPN1 | |
| SCHEMBL13290017 | 0.73 | ALDH1A1 (0.51) | MEN1MAPTKMT2ACES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100136459-A1 | ELECTROLYTE CONTAINING OXOCARBON MOLECULE AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-06-03 | — | — | US | disclosed |
| US-20100136459-A1 | ELECTROLYTE CONTAINING OXOCARBON MOLECULE AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100136459-A1 | ELECTROLYTE CONTAINING OXOCARBON MOLECULE AND USE THEREOF | EPCAM, CCNE2, ESR1 | ESR2 13/4885HSD17B1 953/4885HSD17B2 672/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.